Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Annals of Oncology 26 (8), 1604-1620, 2015 | 686 | 2015 |
ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms G Delle Fave, D O''Toole, A Sundin, B Taal, P Ferolla, JK Ramage, ... Neuroendocrinology 103 (2), 119-124, 2016 | 533 | 2016 |
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007 | 368 | 2007 |
ENETS consensus guidelines update for colorectal neuroendocrine neoplasms JK Ramage, WW De Herder, G Delle Fave, P Ferolla, D Ferone, T Ito, ... Neuroendocrinology 103 (2), 139-143, 2016 | 351 | 2016 |
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up K Öberg, P Hellman, P Ferolla, M Papotti Annals of Oncology 23, vii120-vii123, 2012 | 347 | 2012 |
Clinical characterization of familial isolated pituitary adenomas AF Daly, ML Jaffrain-Rea, A Ciccarelli, H Valdes-Socin, V Rohmer, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3316-3323, 2006 | 290 | 2006 |
Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series P Ferolla, A Falchetti, P Filosso, P Tomassetti, G Tamburrano, N Avenia, ... The Journal of Clinical Endocrinology & Metabolism 90 (5), 2603-2609, 2005 | 197 | 2005 |
Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ E Baudin, M Caplin, R Garcia-Carbonero, N Fazio, P Ferolla, PL Filosso, ... Annals of Oncology 32 (4), 439-451, 2021 | 185 | 2021 |
Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes C Romei, S Mariotti, L Fugazzola, A Taccaliti, F Pacini, G Opocher, C Mian, ... European Journal of Endocrinology 163 (2), 301-308, 2010 | 135 | 2010 |
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label … P Ferolla, MP Brizzi, T Meyer, W Mansoor, J Mazieres, C Do Cao, H Léna, ... The Lancet Oncology 18 (12), 1652-1664, 2017 | 134 | 2017 |
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET … A Faggiano, P Ferolla, F Grimaldi, D Campana, M Manzoni, MV Davì, ... Journal of endocrinological investigation 35, 817-823, 2012 | 133 | 2012 |
Multiple endocrine neoplasia syndrome type 1: institution, management, and data analysis of a nationwide multicenter patient database F Giusti, L Cianferotti, F Boaretto, F Cetani, F Cioppi, A Colao, MV Davì, ... Endocrine 58, 349-359, 2017 | 123 | 2017 |
ENETS consensus conference participants. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best … ME Caplin, E Baudin, P Ferolla, P Filosso, M Garcia-Yuste, E Lim, ... Ann Oncol 26 (8), 1604-20, 2015 | 111 | 2015 |
Tumorlets, multicentric carcinoids, lymph-nodal metastases, and long-term behavior in bronchial carcinoids P Ferolla, N Daddi, M Urbani, A Semeraro, R Ribacchi, P Giovenali, ... Journal of Thoracic Oncology 4 (3), 383-387, 2009 | 94 | 2009 |
Surgical treatment of neuroendocrine tumors of the lung N Daddi, P Ferolla, M Urbani, A Semeraro, N Avenia, R Ribacchi, F Puma, ... European journal of cardio-thoracic surgery 26 (4), 813-817, 2004 | 85 | 2004 |
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers P Ferolla, A Faggiano, G Mansueto, N Avenia, MG Cantelmi, P Giovenali, ... Journal of endocrinological investigation 31, 277-286, 2008 | 82 | 2008 |
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses P Ferolla, A Faggiano, F Grimaldi, D Ferone, G Scarpelli, V Ramundo, ... Journal of Endocrinological Investigation 35, 326-331, 2012 | 78 | 2012 |
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors A Faggiano, G Mansueto, P Ferolla, F Milone, MLB de del Caro, ... Journal of endocrinological investigation 31, 216-223, 2008 | 76 | 2008 |
Proceedings of the IASLC international workshop on advances in pulmonary neuroendocrine tumors 2007 E Lim, P Goldstraw, AG Nicholson, WD Travis, JR Jett, P Ferolla, ... Journal of Thoracic Oncology 3 (10), 1194-1201, 2008 | 69 | 2008 |
Cinacalcet therapy in patients affected by primary hyperparathyroidism associated to Multiple Endocrine Neoplasia Syndrome type 1 (MEN1) F Giusti, L Cianferotti, G Gronchi, F Cioppi, L Masi, A Faggiano, A Colao, ... Endocrine 52, 495-506, 2016 | 56 | 2016 |